Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
412 participants
OBSERVATIONAL
2021-05-01
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327
Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING
NCT02645968
A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease
NCT05492994
Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
NCT06522334
Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)
NCT02827734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
prospective patient cohort
patients who will undergo the prospective ILD Screening algorithm
chest CT
assessment of interstitial lung disease using chest CT
retrospective patient cohort
patients with diagnosed ILD
chest CT
assessment of interstitial lung disease using chest CT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
chest CT
assessment of interstitial lung disease using chest CT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with a known systemic disease bearing a risk for ILD
* signed informed consent (for prospective part)
Exclusion Criteria
* comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Graz, Department of Internal Medicine, Division of Pulmonology
Graz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
33-023 ex 20/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.